Pharmacogenomics Technology and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pharmacogenomics Technology (Theranostics & CDx) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacogenomics Technology (Theranostics & CDx) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmacogenomics Technology (Theranostics & CDx) Overall Market Size
2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size: 2022 VS 2029
2.2 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmacogenomics Technology (Theranostics & CDx) Players in Global Market
3.2 Top Global Pharmacogenomics Technology (Theranostics & CDx) Companies Ranked by Revenue
3.3 Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Companies
3.4 Top 3 and Top 5 Pharmacogenomics Technology (Theranostics & CDx) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmacogenomics Technology (Theranostics & CDx) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics Technology (Theranostics & CDx) Players in Global Market
3.6.1 List of Global Tier 1 Pharmacogenomics Technology (Theranostics & CDx) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics Technology (Theranostics & CDx) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Markets, 2022 & 2029
4.1.2 Instrument
4.1.3 Reagents and Consumables
4.1.4 Others
4.2 By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue & Forecasts
4.2.1 By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2023
4.2.2 By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2024-2029
4.2.3 By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Mental Diseases
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue & Forecasts
5.2.1 By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2023
5.2.2 By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2024-2029
5.2.3 By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2022 & 2029
6.2 By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue & Forecasts
6.2.1 By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2023
6.2.2 By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2024-2029
6.2.3 By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2029
6.3.2 US Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.3.3 Canada Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.3.4 Mexico Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2029
6.4.2 Germany Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4.3 France Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4.4 U.K. Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4.5 Italy Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4.6 Russia Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4.7 Nordic Countries Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.4.8 Benelux Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2029
6.5.2 China Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.5.3 Japan Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.5.4 South Korea Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.5.5 Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.5.6 India Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2029
6.6.2 Brazil Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.6.3 Argentina Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2029
6.7.2 Turkey Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.7.3 Israel Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
6.7.5 UAE Pharmacogenomics Technology (Theranostics & CDx) Market Size, 2018-2029
7 Pharmacogenomics Technology (Theranostics & CDx) Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.1.4 Illumina Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.1.5 Illumina Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.2.4 Roche Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Agilent
7.3.1 Agilent Company Summary
7.3.2 Agilent Business Overview
7.3.3 Agilent Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.3.4 Agilent Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.3.5 Agilent Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.4.4 Abbott Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Thermofisher
7.5.1 Thermofisher Company Summary
7.5.2 Thermofisher Business Overview
7.5.3 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.5.4 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.5.5 Thermofisher Key News & Latest Developments
7.6 Qiagen
7.6.1 Qiagen Company Summary
7.6.2 Qiagen Business Overview
7.6.3 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.6.4 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.6.5 Qiagen Key News & Latest Developments
7.7 Guardant Health
7.7.1 Guardant Health Company Summary
7.7.2 Guardant Health Business Overview
7.7.3 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.7.4 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.7.5 Guardant Health Key News & Latest Developments
7.8 MGI Tech Co., Ltd.
7.8.1 MGI Tech Co., Ltd. Company Summary
7.8.2 MGI Tech Co., Ltd. Business Overview
7.8.3 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.8.4 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.8.5 MGI Tech Co., Ltd. Key News & Latest Developments
7.9 Amoydx Biology
7.9.1 Amoydx Biology Company Summary
7.9.2 Amoydx Biology Business Overview
7.9.3 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.9.4 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.9.5 Amoydx Biology Key News & Latest Developments
7.10 Genomics
7.10.1 Genomics Company Summary
7.10.2 Genomics Business Overview
7.10.3 Genomics Pharmacogenomics Technology (Theranostics & CDx) Major Product Offerings
7.10.4 Genomics Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global Market (2018-2023)
7.10.5 Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pharmacogenomics Technology (Theranostics & CDx) Market Opportunities & Trends in Global Market
Table 2. Pharmacogenomics Technology (Theranostics & CDx) Market Drivers in Global Market
Table 3. Pharmacogenomics Technology (Theranostics & CDx) Market Restraints in Global Market
Table 4. Key Players of Pharmacogenomics Technology (Theranostics & CDx) in Global Market
Table 5. Top Pharmacogenomics Technology (Theranostics & CDx) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharmacogenomics Technology (Theranostics & CDx) Product Type
Table 9. List of Global Tier 1 Pharmacogenomics Technology (Theranostics & CDx) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacogenomics Technology (Theranostics & CDx) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharmacogenomics Technology (Theranostics & CDx) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2024-2029
Table 30. Illumina Company Summary
Table 31. Illumina Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 32. Illumina Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 33. Illumina Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 36. Roche Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Agilent Company Summary
Table 39. Agilent Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 40. Agilent Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 41. Agilent Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 44. Abbott Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. Thermofisher Company Summary
Table 47. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 48. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 49. Thermofisher Key News & Latest Developments
Table 50. Qiagen Company Summary
Table 51. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 52. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 53. Qiagen Key News & Latest Developments
Table 54. Guardant Health Company Summary
Table 55. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 56. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 57. Guardant Health Key News & Latest Developments
Table 58. MGI Tech Co., Ltd. Company Summary
Table 59. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 60. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 61. MGI Tech Co., Ltd. Key News & Latest Developments
Table 62. Amoydx Biology Company Summary
Table 63. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 64. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 65. Amoydx Biology Key News & Latest Developments
Table 66. Genomics Company Summary
Table 67. Genomics Pharmacogenomics Technology (Theranostics & CDx) Product Offerings
Table 68. Genomics Pharmacogenomics Technology (Theranostics & CDx) Revenue (US$, Mn) & (2018-2023)
Table 69. Genomics Key News & Latest Developments
List of Figures
Figure 1. Pharmacogenomics Technology (Theranostics & CDx) Segment by Type in 2022
Figure 2. Pharmacogenomics Technology (Theranostics & CDx) Segment by Application in 2022
Figure 3. Global Pharmacogenomics Technology (Theranostics & CDx) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacogenomics Technology (Theranostics & CDx) Revenue in 2022
Figure 8. By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 16. US Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 20. Germany Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 21. France Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 28. China Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 32. India Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 34. Brazil Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share, 2018-2029
Figure 37. Turkey Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pharmacogenomics Technology (Theranostics & CDx) Revenue, (US$, Mn), 2018-2029
Figure 41. Illumina Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Agilent Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Genomics Pharmacogenomics Technology (Theranostics & CDx) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
